A rare drug-resistant bacterium has spread throughout U.S. military hospitals around the world, killing at least 27 since the start of the Iraq war.
Acinetobacter Baumann has popped up in facilities like Walter Reed Army Medical Center in Washington and the Army's Landstuhl Regional Medical Center in Germany -- infecting an unknown number of soldiers' and civilians' bloodstreams, cerebrospinal fluid, bones and lungs -- The Los Angeles Times reported Sunday.
Since 2001, the percentage of admissions caused by the antibiotic-resistant virus has increased from 2 percent to 12 percent, the newspaper said.
Like many other types of bacteria, Acinetobacter Baumann was once easily controlled by antibiotics, but has become increasingly resistant over the last few decades as use of the drugs has become widespread.
After a 2003 outbreak aboard the U.S. hospital ship Comfort in the Persian Gulf, researchers struggled to find the source of the outbreak, the Times reported. In May, a group of researchers narrowed the source of the infection down to field hospitals in Iraq and Kuwait, though some doctors and scientists still have doubts.
The number of cases has begun to subside and doctors have identified the most effective drugs, but now they wonder if it is the bacterium that is sickening soldiers -- or if it is just a marker of vulnerability in the sickest patients.
Copyright 2007 by United Press International
Related stories:
Drug-resistant tuberculosis on the increase in the UK
A changing population structure and ongoing migration have increased cases of drug resistant tuberculosis, according to a study published onbmj.com today.
Computers help chemists fight emerging infections
Computer analysis of existing drugs may be key to fighting new infectious agents and antibiotic-resistant pathogens like deadly tuberculosis strains and staph ‘superbugs.’ Researchers in Canada say the use of such “emergency discovery” technology could save time, money and lives during a sudden outbreak or a bioterrorism attack. They reported here today at the 234th national meeting of the American Chemical Society.
Scientists assess risk of potential flu pandemic spread via global airlines
An Indiana University School of Informatics-led team of researchers has constructed a model that predicts how an emerging pandemic influenza might spread across the globe by airliners.
Researchers discover surprising drug that blocks malaria
Northwestern University researchers have discovered how malaria parasites persuade red blood cells to engulf them -- and how to block the invading parasites. The malaria marauders hack into the red cell's signaling system and steal the molecular equivalent of its password to spring open the door to the cell. But researchers have found that a common blood pressure medication – propranolol – jams the signal to prevent the parasite from breaking in.
Enzyme study may lead to new SARS drugs
Scientists at the University of Illinois say a study of an enzyme that causes severe acute respiratory syndrome may lead to new drugs.
UW scientists unravel mystery of how flu viruses replicate
Like any other organism, an influenza virus's success in life is measured by its genetic track record, its ability to pass on genes from one generation to the next. But although much is known about the genes and inner workings of flu viruses, how the microbe organizes its genetic contents to seed future generations of viruses has remained an enduring mystery of biology.
US controls bird flu vaccines over bioweapon fears
(AP) -- When Indonesia's health minister stopped sending bird flu viruses to a research laboratory in the U.S. for fear Washington could use them to make biological weapons, Defense Secretary Robert Gates laughed and called it "the nuttiest thing" he'd ever heard.
Statins may prevent miscarriages
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study in mice. In this autoimmune syndrome, the body produces antibodies directed at phospholipids, the main components of cell membranes. This news comes from a study published in the October issue of the
Journal of Clinical Investigation that is currently online in advance of print.